The National Football League Alumni Association (NFLA) recently announced a collaboration with Alliance for Cell Therapy Now–an independent, non-profit group dedicated to advancing safe and effective regenerative cell therapies–to educate its members on the risks, benefits, and science surrounding regenerative medicine and cell therapies. These developing treatments include platelet-rich plasma (PRP), stem cell therapies, bone marrow aspirate (BMAC) and are of great interest to retired professional football players. Many of them live with the toll of years of hard play on the gridiron. However, the newness of these treatments can leave patients with more questions than answers, so the NFLA took the initiative to gather experts in the field to educate, inform, and empower their members.
To that end, Dr. Josh Hackel is honored to serve on the NFL Alumni’s Regenerative Medicine and Cell Therapy Advisory Committee, whose mission is to help guide this educational outreach program. Dr. Hackel’s tenure on this committee echoes his commitment to driving forward the critical work of understanding the potential benefits of cell-based therapies through cutting-edge research and education.
In addition to his work on the Advisory Committee, Dr. Hackel will participate alongside other experts in the webinars the NFLA publishes to educate its members. The Advisory Committee also aims to help NFL Alumni members make informed decisions about locating, evaluating, and enrolling in one of the many cell-based therapy clinical studies currently underway across the country.
To read more about the vital work of the NFL Alumni Association, or to watch the past and future webinars, visit the Regenerative Medicine and Cell Therapy landing page.